Cyclin D1 amplification in tongue and cheek squamous cell carcinomas

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 9, 2011, Pages 2199-2204

  Mahdey, Haydar M ^a   Ramanathan, Anand ^a   Ismail, Siti Mazlipah ^a   Abraham, Mannil Thomas ^b   Jamaluddin, Marhazlinda ^a   Zain, Rosnah Binti ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b Hospital Tengku Ampuan Rahimah   (Malaysia)

Author keywords

Cheek; Fluorescent in situ hybridization; Oral SCC; Tongue

Indexed keywords

CCND1 PROTEIN, HUMAN; CYCLIN D1; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CROSS-SECTIONAL STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETICS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TONGUE TUMOR;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; CYCLIN D1; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84866266165     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Akervall J, Borg A, Dictor M, et al (2002). Chromosomal translocation involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol, 20, 45-52.
2. Allison P, Locker D and Feine JS (1998). The role of diagnostic delays in the prognosis of oral cancer: a review of the literature. Oral Oncol, 34, 161-70.
3. Asano K, Sakamoto H, Sasaki H, et al (1995). Tumorigenicity and gene amplification potentials of cyclin D1-overexpressing NIH3T3 cells. Biochem Biophys Res Commun, B, 1169-76.
4. Bartkova J, Lukas J, Muller H, et al (1995). Abnormal pattern of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res, 55: 949-56.
5. Bekri S, Adelaide J, Merscher S, et al (1997). Detailed map of a region commonly amplified at 11q13-q14 in human breast carcinoma. Cytogenet Cell Genet, 79, 125-31.
6. Bell RB, Kademani D, Homer L, et al (2007). Tongue cancer: Is there a difference in survival compared with other subsites in oral cavity? J Oral Maxillofac Surg, 65, 229-36.
7. Berenson JR, Yang J, Mickel RA, et al (1989). Frequent amplification of bcl-1 locus in head and neck squamous cell carcinomas. Oncogene, 4, 1111-6.
8. Chen YK, Huang HC, Lin LM and Lin CC (1999). Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol, 35, 173-9.
9. Chitapanarux I, Lorvidhaya V, Sittitrai P, et al (2006). Oral cavity cancers at a young age: analysis of patient, tumor and treatment characteristics in Chiang Mai University Hospital. Oral Oncol, 42, 83-8.
10. Coqueret O (2002). Linking cyclin to transcriptional control. Gene, 299, 35-55.
11. Fuji M, Ishiguro R, Yamashita T, et al (2001). Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue. Cancer Lett, 172, 187-92.
12. Hopman AH, Ramaekers FC, Raap AK, et al (1988). In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochem, 89, 307-16.
13. Hvang X, Gollin SM, Raja S, et al (2002). High-resolution mapping of 11q13 amplicon and identification of genes, TAOS1, that is amplified and overexpressed in oral cancer cell lines. Proc Natl Acad Sci USA, 99, 11369-74.
14. Izzo JG, Papadimitrakopoulou VA, Li QX, et al (1998). Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene, 17, 2313-22.
15. Jin Y, Hoglund M, Jin C, et al (1998). FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer, 22, 312-20.
16. Kasperts N, Slotman B, Leemans CR, et al (2005). A review on re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol, 41, 225-43.
17. Kitagawa Y, Ueda M, Ando N, et al (1991). Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res, 51, 1504-8.
18. Koyomoto R, Kumazawa H, Toda Y, et al 1(997). Cyclin D1 gene amplification is a more potent prognostic factor than its protein overexpression in human head and neck squamous cell carcinoma. Int J Cancer, 74, 576-81
19. Liao C-T, Huang S-F, Chen I-H, et al (2010). Tongue and buccal mucosa carcinoma: Is there a difference in outcome? Ann Surg Oncol, ??, 1174-1.
20. Llewellyn CD, Linklater K, Bell J, et al (2003). Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol, 39, 106-14.
21. Lovec H, Sewing A, Lucibello FC, et al (1994). Oncogenic activity of cyclin D1 revealed through cooperation with H-ras: link between cell cycle control and malignant transformation. Oncogene, 9, 323-6.
22. Lui CJ, Chang KW, Chao SY, et al (2004). The molecular marker for prognostic evaluation of areca-associated buccal squamous cell carcinoma. J Oral Pathol Med, 33, 327-34.
23. Merdith SD, Levine PA, Burns JA, et al (1995). Chromosome 11q13 amplification in head and neck squamous cell carcinoma: assosiation with poor prognosis. Arch Otolaryngol Head Neck Surg, 121, 790-4.
24. Miyamoto R, Uzawa N, Nagaoka S, et al (2002). Potential marker of Oral Squamous Cell Carcinoma Aggressiveness detected by fluorescence in situ hybridization in fine-needle aspiration biopsies. Cancer, 95, 2152-9.
25. Miyamoto R, Uzawa N, Nagaoka S, et al (2003). Prognostic of cyclin D1 amplification and overexpression in oral squamous cell carcinomas. Oral Oncol, 39: 610-18.
26. Mori M, Tokino T, Yanagisawab A, et al (1992). Association between chromosome 11q13 amplification and prognosis of patients with oesophageal carcinomas. Eur J Cancer, 28A: 755-7.
27. Muller D, Million R, Velten M, et al (1997). Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: correlation with clinical outcome. Eur J Cancer, 33: 2203-10.
28. Myo K, Uzawa N, Miyamoto R, et al (2005). Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage I and II sqyuamous cell carcinoma of the oral cavity. Cancer, 104, 2709-16.
29. Nagasawa S, Onda M, Sasajima K, et al (2001). Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma. J Surg Oncol, 78, 208-14.
30. Namazie A, Alavi S, Olopade OI, et al (2002). Cyclin D1 amplification and P16 (MTS1/CDK4I) deletion correlate with poor prognosis in hed and neck tumors. Laryngoscope, 112, 472-81.
31. Nimeus E, Baldetorp B, Bendahl P-O, et al (2004). Amplification of the cyclin D1 gene is associated with tumor subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck. Oral Oncol, 40, 624-9.
32. Parkin DM, Pisani P and Ferlay J (1999). Global cancer statistics. CA Cancer J Clin, 49, 33-64, 1.
33. Petruzzelli GJ, Knight FK, Vandevender D, et al (2003). Posterior marginal mandibulectomy in the management of cancer of the oral cavity and oropharynx. Otolaryngol Head Neck Surg, 129, 713-9.
34. Petti S and Scully C (2005). Oral cancer: the association between nation-based alcohol-drinking profiles and oral cancer mortality. Oral Oncol, 41, 828-34.
35. Roelofs H, Schuuring E, Wiegant J, et al (1993). Amplification of 11q13 region in human carcinoma cell lines: a mechanistic view. Genes Chromosomes Cancer, 7, 74-84.
36. Sathyan KM, Sailasree R, Jayasurya R, et al (2006). Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma. J Cancer Res Clin Oncol, 132, 601-9.
37. Sauter ER, Herlyn M, Liu S-C, et al (2000). Prolonged response to antisense cyclin D1 in human squamous cancer xenograft model. Clin Cancer Res, 6, 654-60.
38. Schuuring E (1995). The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes-a review. Gene, 159, 83-96.
39. Scully C, Bedi R (2000). Ethnicity and oral cancer. Lancet Oncol, 1, 37-42.
40. Shaw RJ, McGlashan G, Woolgar JA, et al (2009). Prognostic importance of site in squamous cell carcinoma. Oral Oncol, 47, 356-9.
41. Shinozaki H, Ozawa S, Ando N et al (1996). Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res, 2, 1155-61.
42. Siar CH, Ng KH, Mah CF, et al (1990). Oral squamous cell carcinoma in Penisular Malaysia. Asian Med J, 33, 697-703.
43. Williams ME, Gaffey MJ, Weiss LM, et al (1993). Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg, 119, 1238-43.
44. Warnakulasuriya S, Sutherland G and Scully C (2005). Tobacco, oral cancer, and treatment of dependence. Oral Oncol, 41, 244-60.
45. Woolgar JA, Rogers S and West CR (1999). Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol, 35, 257-65.
46. Yao M, Dornfeld KJ, Buatti JM, et al (2005). Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys, 63, 410-21.
47. Zain RB and Ghazali N (2001). A review of epidemiological studies of oral cancer and precancer in Malaysia. Annal Dent Univ Malaya, 8, 50-6.
48. Zain RB, Raja Latifah RJ, Razak IA, et al (2005). Oral cancer and Precancer in Malaysia - The Database and Tissue Resource Bank. Oral Oncology, MacMillan India 10, pp3-12.